Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

McGill University

$105,000.00

An Integrative Single Cell Epigenetic Map for the study of Type-2 Diabetes.

FY 2023-24

Summary
Type-2 Diabetes Mellitus (T2D) is a heritable disease where our ability to secrete and respond to insulin is impaired. Despite advances in genetics and the development of new technologies, there are still many obstacles to overcome in the study of Type-2 Diabetes which is influenced by networks of genes in different types of cells. Representing 90 percent of diabetes cases in Canada, and with nearly 500 new diagnoses every day, understanding the genetic causes behind Type-2 Diabetes is crucial to finding an effective treatment. In addition, studying the mechanisms causing the disease to disproportionately affect individuals of non-European ancestry is a key concern for establishing equal opportunity for treatment and care. Despite efforts to uncover the genetic machinery behind the disease, its involvement in different types of cells across many tissues such as the pancreas, liver and adipose tissue have made it increasingly difficult to elucidate. To this end, this project proposes the use of an innovative computational tool which will use data from different genetic markers to identify genes and regions of DNA that are dysfunctional in Type-2 Diabetes in specific cell types. Finding these key features will contribute to the construction of gene networks for specific types of cells. Through this project, we will be able to create an atlas for Type-2 Diabetes representing the key gene networks that promote its development in different cells. This atlas will provide researchers with a key set of genetic targets that will contribute to earlier disease detection and the development of reliable and accessible beta cell transplant therapy. Data from patients of different ancestries and sex will help ensure our findings are applicable to a diverse range of patients.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
497059
Name
Osakwe Adrien
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
An Integrative Single Cell Epigenetic Map for the study of Type-2 Diabetes.
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Genomics; Metabolism; Single Cell Genomics; Statistical Modeling; Type-2 Diabetes
Abstract
Type-2 Diabetes Mellitus (T2D) is a heritable disease where our ability to secrete and respond to insulin is impaired. Despite advances in genetics and the development of new technologies, there are still many obstacles to overcome in the study of Type-2 Diabetes which is influenced by networks of genes in different types of cells. Representing 90 percent of diabetes cases in Canada, and with nearly 500 new diagnoses every day, understanding the genetic causes behind Type-2 Diabetes is crucial to finding an effective treatment. In addition, studying the mechanisms causing the disease to disproportionately affect individuals of non-European ancestry is a key concern for establishing equal opportunity for treatment and care. Despite efforts to uncover the genetic machinery behind the disease, its involvement in different types of cells across many tissues such as the pancreas, liver and adipose tissue have made it increasingly difficult to elucidate. To this end, this project proposes the use of an innovative computational tool which will use data from different genetic markers to identify genes and regions of DNA that are dysfunctional in Type-2 Diabetes in specific cell types. Finding these key features will contribute to the construction of gene networks for specific types of cells. Through this project, we will be able to create an atlas for Type-2 Diabetes representing the key gene networks that promote its development in different cells. This atlas will provide researchers with a key set of genetic targets that will contribute to earlier disease detection and the development of reliable and accessible beta cell transplant therapy. Data from patients of different ancestries and sex will help ensure our findings are applicable to a diverse range of patients.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Osakwe, Adrien
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McGill University - $105,000 Grant (2023-24) | Canada Spends